EWTX - Edgewise Therapeutics names new chief medical officer

Edgewise Therapeutics ([[EWTX]] -3.0%) appointed Joanne M. Donovan, M.D., Ph.D. as chief medical officer to be responsible for leading clinical, medical and regulatory strategy and operations for the company’s pipeline, including EDG-5506, the company's lead product candidate that is advancing in clinical development for Duchenne and Becker muscular dystrophy."Having led multiple rare disease clinical programs through all phases of development, from discovery to approvals, Dr. Donovan brings strong leadership capabilities and a broad skill set to Edgewise," president & CEO Kevin Koch, Ph.D. commented.Most recently, Dr. Donovan served as Chief Medical Officer and SVP, Clinical Development at Catabasis, a biopharmaceutical company focused on rare diseases.

For further details see:

Edgewise Therapeutics names new chief medical officer